Four Confluent insiders have sold $341 million combined. Board member Alyssa Henry ($179M, 662 transactions), co-founder Neha Narkhede ($70M), and two others have all been selling. Three have exited completely.
Credo Technology's COO Yat Tung Lam has sold $293.7 million and CEO William Brennan $112.7 million — a combined $406M at the AI networking chip company with 33 recent Form 4 filings.
Four Carvana insiders have sold $751 million combined. CPO Daniel Gill ($299.7M) and President Thomas Taira ($86.2M) have both exited to zero shares as the stock recovers from near-bankruptcy.
Two Nvidia executives have sold $423 million combined across 32 recent filings. EVP Operations Debora Shoquist leads with $252.1M while CFO Colette Kress has sold $171.2M.
Joel Reiss, Co-Chief Operating Officer of TransDigm Group, has sold $119 million across 444 transactions with 26 recent Form 4 filings at the controversial defense supplier.
Booking Holdings CEO Glenn Fogel has generated $190.8 million in stock sales across 877 transactions. The $160 billion travel giant's top two insiders have filed 47 Form 4s recently.
Alphabet CEO Sundar Pichai has sold $794.9 million across 1,233 transactions and exited to zero shares. Combined with Chairman Hennessy's $64.4M, three insiders have sold $874 million.
Three of four filing insiders at Hims & Hers Health have sold down to zero shares. The PAO, Chief Policy Officer, and CMO have all completely exited while the COO continues selling.
Four Roivant Sciences insiders have generated $1.41 billion in combined sales. Hedge fund manager Daniel Gold ($619M), QVT Financial ($578M), Keith Manchester ($170M), and President Sukhatme ($45M) all hold zero shares.
Three Broadcom executives have filed 83 Form 4 filings with combined career sales of $327 million. The CLO, CFO, and President of Semiconductor Solutions are all actively selling.
Charles and Andrew Mills have purchased a combined $149.8 million in Madrigal Pharmaceuticals stock, one of the largest insider buying events in recent biotech history.
Every insider who recently filed at Arrowhead Pharmaceuticals now holds zero shares. CEO Christopher Anzalone has sold $85.3 million across 170 transactions.
CrowdStrike's entire C-suite is selling. CEO George Kurtz has amassed $702 million in career sales while President Michael Sentonas exits his position completely with $93 million sold.
Four United Therapeutics insiders with combined career sales of $587 million have all exited their positions completely. The President, EVP, and two directors sold every remaining share.
Seven SoundHound AI executives are selling aggressively, with the COO and CSO both exiting their positions entirely. Combined insider sales have reached $78 million.
Five Insmed insiders sold $11.5M in INSM stock, led by CEO Lewis ($4.7M, $96.1M career) and CMO Flammer ($4.7M, $74M career). CFO Bonstein adds $43.1M in career sales.